Table 1 Baseline characteristics of the 173 patients
Total, n = 173 (%) | Restenosis, n = 34 (%) | No restenosis, n = 139 (%) | P value | |
|---|---|---|---|---|
Male | 135 (78.0) | 27 (79.4) | 108 (77.7) | 0.86 |
Age, Y | 69.54 ± 10.50 | 67.53 ± 11.62 | 70.03 ± 10.19 | 0.21 |
Smoking | 93 (53.76) | 18 (52.94) | 75 (53.96) | 0.39 |
Hypertension | 97 (56.07) | 18 (52.94) | 79 (56.83) | 0.66 |
Diabetes mellitus | 95 (54.91) | 16 (47.06) | 79 (56.83) | 0.10 |
Statin treatment | 38 (21.97) | 8 (23.53) | 30 (21.58) | 0.81 |
CAD | 47 (27.12) | 10 (29.41) | 37 (34.26) | 0.74 |
TASC II classification | ||||
TASC A | 9 | 3 | 6 | 0.33 |
TASC B | 88 | 14 | 74 | |
TASC C | 76 | 17 | 59 | |